What is Advanced Medical Solutions Group FCF Yield %?
Advanced Medical Solutions GroupCHIX:AMSL +14.17%93 FCF Yield % is 3.30 as of Jun. 26, 2026, which is 18% above its 10-year median of 2.80. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.71 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 71.58% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Advanced Medical Solutions Group's FCF Yield % or its related term are showing as below:
CHIX:AMSl'
s FCF Yield % Range Over the Past 10 Years
Min: 0.45 Med: 2.8 Max: 4.74
Current: 3.3
During the past 13 years, the highest FCF Yield % of Advanced Medical Solutions Group was 4.74%. The lowest was 0.45%. And the median was 2.80%.
CHIX:AMSl's FCF Yield % is ranked better than 71.58% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs CHIX:AMSl: 3.30
Advanced Medical Solutions Group FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Advanced Medical Solutions Group FCF Yield % Related Terms
Advanced Medical Solutions Group FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group FCF Yield % Chart
CHIX:AMSL vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group (CHIX:AMSL) has a FCF Yield % of 3.30 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Advanced Medical Solutions Group and its competitors. This is 18% above median its historical median of 2.80. Over the past decade, Advanced Medical Solutions Group's FCF Yield % has ranged from 0.45 to 4.74. According to the industry distribution chart, Advanced Medical Solutions Group ranks #243 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 28.4%.
Is Advanced Medical Solutions Group's FCF Yield % too high?
Advanced Medical Solutions Group's current FCF Yield % of 3.30 is 18% above median its 10-year median of 2.80. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 4.74. Based on the distribution chart, Advanced Medical Solutions Group ranks #243 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #243 out of 855 companies for FCF Yield %. This puts Advanced Medical Solutions Group in the upper half of its industry. Historically, Advanced Medical Solutions Group's own FCF Yield % has ranged from 0.45 to 4.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Advanced Medical Solutions Group and its competitors. Advanced Medical Solutions Group's current FCF Yield % is 3.30, which is 18% above median its own 10-year median of 2.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.71, compared to a current price of £2.78 — trading 25.1% below its estimated fair value. The current FCF Yield % is 3.30, which is 18% above median its 10-year median of 2.80. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current FCF Yield % is 3.30 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.78 is trading 25.1% below its estimated GF Value™ of £3.71.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
FCF Yield %: 3.30 (18% above median its 10-year median of 2.80)
GF Value™: £3.71 vs. price of £2.78 (25.1% below fair value)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
